ANZICS CTG Endorsed Study
ADRENAL Consent Study
A multicentre, prospective, observational study of the process of obtaining consent from potential participants or their substitute decision-makers in the adjunctive corticosteroid treatment in critically ill patients with septic shock (ADRENAL) Study
Study Description
The ADRENAL Consent Study is a multicentre, prospective, observational study which aims to describe the process through which written informed consent is sought from potential participants or their substitute decision-makers for the adjunctive corticosteroid treatment in critically ill patients with septic shock (ADRENAL) Study. The ADRENAL study is a randomised controlled trial of the effect of hydrocortisone on mortality in critically ill patients with septic shock.
Aims:
- To describe the rates of consent for enrolment and continued participation in the ADRENAL Study.
- To describe professional characteristics of the person seeking consent and the contextual features of the consent encounter, including coenrolment and readability of the information and consent form.
- To determine the time required by research coordinators to obtain a consent decision from potential ADRENAL participants or their substitute decision-makers.
Management Committee
Heidi Buhr (Chair), Deborah Cook, David Gattas, Julie Potter, Dorrilyn Rajbhandari, Kelly Thompson, Bala Venkatesh, and Leonie Weisbrodt.
Funding
Intensive Care Foundation $5,000
Reference
CTG1213‐003
Contact
Heidi Buhr (email)